FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a peptide consisting of the amino acid sequence YGAGAGAGY (SEQ ID NO: 1), or to a pharmaceutically acceptable salt thereof, usable for treating or preventing insulitis or type 1 diabetes.
EFFECT: treatment of insulitis or type 1 diabetes using the new peptide.
6 cl, 6 dwg, 3 tbl, 2 ex
Authors
Dates
2022-11-17—Published
2020-03-05—Filed